A pension fund has filed a class action against the group in the US, alleging GSK and three executives including its boss, Emma Walmsley ... Richard Tanner, a scientist at Glaxo, a predecessor ...

As first quarter earnings begin, executives are confronting market turmoil, regulatory instability and the threat of U.S.

The results are a boost for GSK and boss Emma Walmsley (pictured), who has been trying to improve the pipeline of new drugs and vaccines. Blenrep could be worth more than £3billion in annual ...

companies have an important role to play – and addressing the carbon emissions from inhalers is a key part of this,” said GSK chief executive Emma Walmsley. The low-carbon Ventolin is the ...

Meanwhile, Dame Emma Walmsley, GSK’s chief executive ... magazines that vaccines were linked to autism in children and scientists and managers were covering it up. Any link has repeatedly ...

GSK chief executive Emma Walmsley said the new HQ is "an important ... for even closer collaboration with the city's world-class science, academic, and healthcare institutions," she added.

I loved speaking with Nicolai Tangen on all things people, culture, leadership and how these fuel the innovation in science and technology that’s helping us to change the course of disease.

A pension fund has filed a class action against the group in the US, alleging that GSK and three executives, including its boss, Emma Walmsley, misled investors ... Richard Tanner, a scientist at ...